tiprankstipranks
Autolus Therapeutics (AUTL)
NASDAQ:AUTL

Compare Autolus Therapeutics (AUTL) vs. Competitors

926 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Autolus Therapeutics
$1.49
$396.55M
30.70%
6 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$2.90
$27.21M
-1.38
-80.13%
4 Buy
3 Hold
0 Sell
Moderate Buy
Larimar Therapeutics
$4.85
$528.76M
-1.68
172.47%
5 Buy
0 Hold
0 Sell
Strong Buy
Benitec Biopharma
$11.42
$392.33M
-13.08
-4.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$5.99
$322.76M
-11.41
70.66%
4 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$12.87
$498.80M
-5.28
211.62%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AUTL
Autolus Therapeutics
1.49
0.15
11.19%
TVRD
Tvardi Therapeutics
2.90
-13.75
-82.58%
LRMR
Larimar Therapeutics
4.85
2.98
159.36%
BNTC
Benitec Biopharma
11.42
-1.85
-13.94%
DMAC
Diamedica Therapeutics
5.99
2.45
69.21%
CTNM
Contineum Therapeutics, Inc. Class A
12.87
8.88
222.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts